|
Volume: 35 Issue: 1 Year: 2023
|
|
The use of transdermal fentanyl in chronic non-malignant pain [Ağrı]
Ağrı. 2005; 17(1): 39-44
|
|
The use of transdermal fentanyl in chronic non-malignant painTaylan Akkaya, Murat Sayın, Haluk GümüşSsk Ankara Training Hospital, Department Of Anesthesiology And Intensive Care, Ankara, Turkey
Twelve non-malignant pain patients were followed-up for pain, improvement in the quality of life, satisfaction for pain therapy and side effects for a mean of 95.25 days with the use of transdermal fentanyl (TDF). During this period a mean of 32.04 mg/gr TDF was used. While the score of pain at rest was decreased by 52.6%, mean pain score on movement was decreased by 45.2% (p= 0.002). Quality of sleep improved and impairment of daily living by pain was decreased significantly (p= 0.002). Satisfaction by the pain therapy was 83.3% and the most common side effect was nausea (16.8%). TDF may be a good alternative in the therapy of chronic non-malignant pain if patients were selected carefully.
Kronik non-malign ağrılı hastalarda transdermal fentanilin yeriTaylan Akkaya, Murat Sayın, Haluk GümüşSsk Ankara Training Hospital, Department Of Anesthesiology And Intensive Care, Ankara, Turkey
Taylan Akkaya, Murat Sayın, Haluk Gümüş. The use of transdermal fentanyl in chronic non-malignant pain. Ağrı. 2005; 17(1): 39-44
Corresponding Author: Taylan Akkaya |
|
|
|
|